Stock Events

Stock Events

CytomX Therapeutics (6C1.STU) Q2 2026 Earnings

30AprConfirmed

Next

-0.1

0.23

0.56

0.9

Details

Expected EPS

-0.1032870429

Actual EPS

N/A

Surprise EPS

0.1

Surprise Percent

+100%

Description

CytomX Therapeutics (6C1.STU) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.